Redeye on päivitellyt näkemyksiään Optomedista. Tilauksella koko juttu luettavissa.
Optomed: Portable Cameras and AI Reshaping Eye Screening
2026-07-28
Optomed trades below Redeye’s Fair Value estimate of EUR 3.45 per share, has a Market Edge score of 5 for Value (Cheap) and 1 for Momentum (Very Weak). We spoke with analyst Gustaf Meyer about what the company does, Aurora AEYE’s growth prospects, and other key topics.
https://www.redeye.se/research/1177656/optomed-portable-cameras-and-ai-reshaping-eye-screening